Shopping Cart
- Remove All
- Your shopping cart is currently empty
PD173952 is a tyrosine (Src) kinase and Myt1 inhibitor with antitumor activity, inhibits Lyn, Abl and Csk, and induces Bcr-Abl-dependent hematopoietic cell apoptosis.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | 93 € | In Stock | |
5 mg | 244 € | In Stock | |
10 mg | 362 € | In Stock | |
25 mg | 596 € | In Stock | |
50 mg | 843 € | In Stock |
Description | PD173952 is a tyrosine (Src) kinase and Myt1 inhibitor with antitumor activity, inhibits Lyn, Abl and Csk, and induces Bcr-Abl-dependent hematopoietic cell apoptosis. |
In vitro | METHODS: K562 cells were treated with PD173952 (0.05-1μM, 12 hours), and the protein expression levels of p210Bcr-Abl or CrkL were detected by Western Blot. RESULTS:PD173952 could inhibit the tyrosine phosphorylation of p210 (Bcr-Abl antibody) and CrkL in K562 cells in a concentration-dependent manner. [1] |
Alias | PD-173952, PD 173952 |
Molecular Weight | 482.36 |
Formula | C24H21Cl2N5O2 |
Cas No. | 305820-75-1 |
Smiles | O=C1C(=CC=2C=NC(=NC2N1C)NC3=CC=C(C=C3)N4CCOCC4)C5=C(Cl)C=CC=C5Cl |
Relative Density. | 1.422 g/cm3 (Predicted) |
Storage | store at low temperature,keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 15 mg/mL(31.10 mM), Sonication is recommended. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.